Peter A. Von Dem Borne
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Long-term outcome of a DLI-based treatment strategy in patients with relapsed AML after TCD allogeneic stem cell transplantation is hampered by GvHD and late relapse.
Journal: Transplantation and cellular therapy
Published: June 02, 2026
Simulation-Based Evaluation of Busulfan Sampling Strategies in Adults and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Journal of clinical pharmacology
Published: May 20, 2026
Clinical Validation of Venetoclax Volumetric Microsampling in Patients with Leukemia with Assessment of Whole-Blood-to-Plasma Conversion Strategies and Self-Microsampling Feasibility.
Journal: Clinical pharmacokinetics
Published: December 12, 2025
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).
Journal: Bone marrow transplantation
Published: November 04, 2025
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT.
Journal: Bone marrow transplantation
Published: June 27, 2025
Inflammation-driven variability in drug metabolism: Insights from voriconazole treatment of HSCT recipients.
Journal: British journal of clinical pharmacology
Published: June 19, 2025
Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.
Journal: Frontiers in immunology
Published: May 28, 2025
Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation.
Journal: JACC. Advances
Published: May 08, 2025
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/ refractory acute myeloid leukemia.
Journal: Haematologica
Published: May 08, 2025
Filgrastim after autologous stem cell transplantation shortens time to neutrophil recovery and hospital stay.
Journal: Annals of hematology
Published: January 15, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT.
Journal: American journal of hematology
Published: November 24, 2024
Last Updated: 09/26/2026